» Articles » PMID: 24816987

Epigenetics in Esophageal Cancers

Overview
Journal Cell Tissue Res
Date 2014 May 13
PMID 24816987
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Esophageal cancers are a challenging upper gastrointestinal tract tumor entity for interdisciplinary oncology. For the two main histotypes, namely esophageal squamous cell carcinomas and Barrett's adenocarcinomas, several genetic aberrations have been shown to contribute to carcinogenesis and progression as well as to represent potential novel targets for therapeutic intervention. This is paralleled by growing insight into epigenetic alterations of esophageal cancers. Studies involving the analyses of human tissue specimens predominantly describe altered patterns of miRNA expression, DNA methylation patterns, and histone marks levels. This review provides a critical update on this increasing knowledge of epigenetic alteration in esophageal cancers by specifically focusing on the translational aspects of epigenetic analyses from human tissue specimens.

Citing Articles

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells.

Zhang Y, Wan Y, Li J, Ju S, Tong X, Wu J Front Immunol. 2025; 16:1556509.

PMID: 40070828 PMC: 11894379. DOI: 10.3389/fimmu.2025.1556509.


Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett's Esophagus.

Laun S, Pierre F, Kim S, Lunz D, Maddala T, Braun J Diagnostics (Basel). 2024; 14(18).

PMID: 39335682 PMC: 11431466. DOI: 10.3390/diagnostics14182003.


Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus.

Laun S, Kann L, Braun J, Gilbert S, Lunz D, Pierre F Am J Gastroenterol. 2024; .

PMID: 39140473 PMC: 11825890. DOI: 10.14309/ajg.0000000000003030.


Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.

Zhao Y, Zhao H, Zhao M, Yu Y, Qi X, Wang J World J Gastroenterol. 2024; 30(20):2638-2656.

PMID: 38855150 PMC: 11154680. DOI: 10.3748/wjg.v30.i20.2638.


Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches.

Ahuja P, Yadav R, Goyal S, Yadav C, Ranga S, Kadian L Cell Biol Toxicol. 2023; 39(6):2437-2465.

PMID: 37338772 DOI: 10.1007/s10565-023-09818-5.